About Tolemy Bio
Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
AI & Machine Learning
Funding Stage
Pre-Seed
Global Headquarters
Cambridge, United Kingdom
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
tolemy.bio
Domain Registered Date
Mar 7, 2024
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $1,643,320 · Pre-Seed
European Biotechnology Magazine
- Milestone
X account created (@TolemyBio)
3 followers
- Milestone
Website domain registered
tolemy.bio
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Tolemy Bio.
Funding History
Pre-Seed
· May 12, 2026
$1,643,320 European Biotechnology Magazine
Founders & Leadership
Press Coverage & Sources
Recently Funded AI & Machine Learning Startups
View allPathos
pathos.com
Series-B+ New York, United States · Oct 2026
Guoke Brain-Computer Intelligence Technology
gkxn.com.cn
Seed Beijing, China · Oct 2026
Knowledge Work
knowledgework.com
Series-B+ Minato, Japan · Oct 2026
Satia
satia.so
Pre-Seed Oct 2026
karta
getkarta.ai
Seed Bangalore, India · Oct 2026
Reduck
reduck.ai
Pre-Seed Oct 2026